REGENERATION

+ STRUCTURE

BioFiller Australia protocol by Alocuro provides technology & training for clinicians to prepare an injectable ‘biogel’ prepared solely from the patient’s own blood components.

The autologous ‘biogel’ can deliver both cellular rejuvenation from platelets & plasma gel volume to support the skin

Prepared individually for each patient, created and injected in a single appointment, BioFiller Australia protocol by Alocuro provides unique platelet & plasma processing technology

Why Clinicians Choose BioFiller by Alocuro Protocol

Start offering BioFiller with the confidence of an established protocol, validated over 5 years by Australian clinicians and supported by 1-on-1 training in your clinic

Exclusive Alocuro protocol. Specialised technology. Comprehensive clinician training.

Looking to introduce BioFiller procedures into your practice?

The BioFiller Australia Protocol provides doctors and nurses access to an established autologous plasma gel preparation technique, supported by Alocuro's specialised platelet-concentrating technology, dedicated training modules and ongoing clinical support.

Launched in 2022 and validated across five years of clinical application and protocol evaluation, commencing with Alocuro’s BioFiller protocol includes technology +  preparation methodology, training and practical education needed to successfully implement the technique into clinical practice.

Best BioFiller protocol Australia

From Blood to BioFiller

01 / COLLECT

Depending on the Alocuro system configuration, 15–30 mL of blood is collected using Alocuro-supplied consumables. Blood is transferred to Alocuro Pro-PRP ARTG-listed, sterile, platelet-concentrating devices.

02 / CONCENTRATE

Using an Alocuro centrifuge & patented protocol, the plasma and platelets are isolated from the remaining blood cells. As the platelets become visible with Alocuro processing, these can be precisely collected within a very small volume of plasma, leaving the remainder of plasma volume to be collected for creating ‘plasma albumin gel’.

03 / PROCESS

The platelet-poor plasma undergoes controlled processing over 14 minutes to create the viscous plasma-albumin-gel, structural component of BioFiller injectate.

04 / COMBINE

Plasma-albumin-gel is combined with high-platelet-dose, liquid PRP to create ‘BioFiller’ according to BioFiller Australia established protocol, and is ready for injection in the same appointment, within less than 30 minutes of blood collection.

DUAL BENEFITS FROM

BIOFILLER AUSTRALIA PROTOCOL

STRUCTURE

Plasma-albumin-gel provides the structural component of BioFiller, and works as a scaffold material below the skin. Made from the patient’s own blood plasma, it provides 4-6 months of volume for suitable patients & where clinically indicated. Published clinical studies of autologous plasma gel have reported improvements in facial volume, skin density and contour, including reductions in nasolabial fold depth. BioFiller gives clinicians an autologous option for addressing volume loss and structural change without introducing a manufactured filler material.

SKIN REJUVENATION

BioFiller does more than provide temporary volume & structure. The concentrated PRP component introduces a platelet-rich fraction containing biologically active growth factors & proteins to support tissue repair and remodelling processes. Clinical literature reports improvements in skin density, texture and elasticity, with supporting evidence of dermal extracellular matrix renewal and collagen-related tissue changes.

The combination of benefits within a single BioFiller Australia protocol addresses both structural support and skin quality within the same autologous preparation.

BioFiller starts with Alocuro PRP protocol

Alocuro Platelet-Concentrator Device to collect 90% available platelets in a small volume of plasma. Remainder of plasma is processed for plasma albumin gel (PAG).

→ PAG PROCESSING: plasma liquid to gel

→ BIOFILLER: mix PAG + liquid platelets

Not all PRP systems deliver the same platelet recovery, concentration capability or preparation consistency.

The BioFiller Australia Protocol is specifically developed for use with the Alocuro Platelet-Concentrating System, combining defined processing parameters with a standardised preparation method.

With platelet collection efficiency independently verified by Australian pathology laboratories, and established protocols guiding preparation, clinicians can work with greater confidence in platelet recovery, PRP composition and procedural reproducibility.

  • ~90% average platelet capture

  • Up to 9× baseline platelet concentration

  • Australian pathology lab verified

Procedure Insights